Treatment of hypertension in sleep apnea

Sleep Apnea: Implications in Cardiovascular and Cerebrovascular Disease

Volumn , Issue , 2016, Pages 180-191

  Friedman, Oded ^a   Logan, Alexander G ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650416242     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (109)

1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455):217-223.
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328(17):1230-1235.
3. Baguet JP, Narkiewicz K, Mallion JM. Update on hypertension management: obstructive sleep apnea and hypertension. J Hypertens 2006; 24(1): 205-208.
4. Hla KM, Young TB, Bidwell T, et al. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994;120(5):382-388.
5. Worsnop CJ, Naughton MT, Barter CE, et al. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998; 157(1):111-115.
6. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000; 160(15):2289-2295.
7. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283(14):1829-1836.
8. Ohayon MM, Guilleminault C, Priest RG, et al. Is sleep-disordered breathing an independent risk factor for hypertension in the general population (13,057 subjects)? J Psychosom Res 2000; 48(6):593-601.
9. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleepdisordered breathing and hypertension. N Engl J Med 2000; 342(19):1378-1384.
10. Duran J, Esnaola S, Rubio R, et al. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163(3 pt 1):685-689.
11. Wright JT Jr., Redline S, Taylor AL, et al. Relationship between 24-H blood pressure and sleep disordered breathing in a normotensive community sample. Am J Hypertens 2001; 14 (8 pt 1):743-748.
12. Sjostrom C, Lindberg E, Elmasry A, et al. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 2002; 57(7):602-607.
13. Tanigawa T, Tachibana N, Yamagishi K, et al. Relationship between sleep-disordered breathing and blood pressure levels in community-based samples of Japanese men. Hypertens Res 2004; 27(7):479-484.
14. Hedner J, Bengtsson-Bostrom K, Peker Y, et al. Hypertension prevalence in obstructive sleep apnoea and sex: a population-based case-control study. Eur Respir J 2006; 27(3):564-570.
15. Kiselak J, Clark M, Pera V, et al. The association between hypertension and sleep apnea in obese patients. Chest 1993; 104(3):775-780.
16. Carlson JT, Hedner JA, Ejnell H, et al. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994; 150(1):72-77.
17. Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999; 160(6):1875-1882.
18. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320(7233):479-482.
19. Kraiczi H, Peker Y, Caidahl K, et al. Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001; 19(11):2071-2078.
20. Grunstein R, Wilcox I, Yang TS, et al. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993; 17(9):533-540.
21. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000; 85(3):1151-1158.
22. Hla KM, Skatrud JB, Finn L, et al. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002; 122(4):1125-1132.
23. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35(3):844-851.
24. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20(11):2183-2189.
25. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005; 19(10):801-807.
26. Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51(1):55-61.
27. Wilcox I, Grunstein RR, Hedner JA, et al. Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993; 16 (6):539-544.
28. Akashiba T, Kurashina K, Minemura H, et al. Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Intern Med 1995; 34(6):528-532.
29. Minemura H, Akashiba T, Yamamoto H, et al. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37(12):1009-1013.
30. Akashiba T, Minemura H, Yamamoto H, et al. Nasal continuous positive airway pressure changes blood pressure "non-dippers" to "dippers" in patients with obstructive sleep apnea. Sleep 1999; 22(7):849-853.
31. Voogel AJ, van Steenwijk RP, Karemaker JM, et al. Effects of treatment of obstructive sleep apnea on circadian hemodynamics. J Auton Nerv Syst 1999; 77(2-3):177-183.
32. Hermida RC, Zamarron C, Ayala DE, et al. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit 2004; 9(4):193-202.
33. Dursunoglu N, Dursunoglu D, Cuhadaroglu C, et al. Acute effects of automated continuous positive airway pressure on blood pressure in patients with sleep apnea and hypertension. Respiration 2005; 72(2):150-155.
34. Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea:effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21(2):241-247.
35. Martinez-Garcia MA, Gomez-Aldaravi R, Soler-Cataluna JJ, et al. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007; 29(5):951-957.
36. Mayer J, Becker H, Brandenburg U, et al. Blood pressure and sleep apnea: results of longterm nasal continuous positive airway pressure therapy. Cardiology 1991; 79(2):84-92.
37. Sanner BM, Tepel M, Markmann A, et al. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002; 15(3):251-257.
38. Dhillon S, Chung SA, Fargher T, et al. Sleep apnea, hypertension, and the effects of continuous positive airway pressure. Am J Hypertens 2005; 18(5 pt 1):594-600.
39. Chin K, Nakamura T, Takahashi K, et al. Falls in blood pressure in patients with obstructive sleep apnoea after long-term nasal continuous positive airway pressure treatment. J Hypertens 2006; 24(10):2091-2099.
40. Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, et al. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007; 132(6):1847-1852.
41. Otsuka R, Ribeiro de Almeida F, Lowe AA, et al. The effect of oral appliance therapy on blood pressure in patients with obstructive sleep apnea. Sleep Breath 2006; 10(1):29-36.
42. Yoshida K. Effect on blood pressure of oral appliance therapy for sleep apnea syndrome. Int J Prosthodont 2006; 19(1):61-66.
43. Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007; 50(2): 417-423.
44. Kuniyoshi FH, Somers VK. Sleep apnea in hypertension: when, how, and why should we treat? Hypertension 2006; 47(5):818-819.
45. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006; 47 (5):840-845.
46. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348 (13):1233-1241.
47. Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169 (3):361-366.
48. Alajmi M, Mulgrew AT, Fox J, et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007; 185(2):67-72.
49. Haentjens P, Van Meerhaeghe A, Moscariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome:evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007; 167(8):757-764.
50. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35(1 pt 1):144-147.
51. Hui DS, To KW, Ko FW, et al. Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness. Thorax 2006; 61(12):1083-1090.
52. Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007; 29(4):720-727.
53. Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males with OSAS. Eur Respir J 2008; 32(6):1488-1496.
54. Faccenda JF, Mackay TW, Boon NA, et al. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 163(2):344-348.
55. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002; 359(9302):204-210.
56. Barbe F, Mayoralas LR, Duran J, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001; 134(11):1015-1023.
57. Robinson GV, Smith DM, Langford BA, et al. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006; 27(6):1229-1235.
58. Montserrat JM, Garcia-Rio F, Barbe F. Diagnostic and therapeutic approach to nonsleepy apnea. Am J Respir Crit Care Med 2007; 176(1):6-9.
59. Borgel J, Sanner BM, Keskin F, et al. Obstructive sleep apnea and blood pressure. Interaction between the blood pressure-lowering effects of positive airway pressure therapy and antihypertensive drugs. Am J Hypertens 2004; 17(12 pt 1):1081-1087.
60. Malik J, Drake CL, Hudgel DW. Variables affecting the change in systemic blood pressure in response to nasal CPAP in obstructive sleep apnea patients. Sleep Breath 2008; 12(1):47-52.
61. Malhotra A, Ayas NT, Epstein LJ. The art and science of continuous positive airway pressure therapy in obstructive sleep apnea. Curr Opin Pulm Med 2000; 6(6):490-495.
62. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107 (1):68-73.
63. McArdle N, Devereux G, Heidarnejad H, et al. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159(4 pt 1):1108-1114.
64. Hui DS, Choy DK, Li TS, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001; 120 (1):170-176.
65. Lindberg E, Berne C, Elmasry A, et al. CPAP treatment of a population-based sample-what are the benefits and the treatment compliance? Sleep Med 2006; 7(7):553-560.
66. Marrone O, Romano S, Insalaco G, et al. Influence of sampling interval on the evaluation of nocturnal blood pressure in subjects with and without obstructive sleep apnoea. Eur Respir J 2000; 16(4):653-658.
67. Frattola A, Parati G, Cuspidi C, et al. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11(10):1133-1137.
68. Sharabi Y, Rabin K, Grossman E. Sleep apnea-induced hypertension: mechanisms of vascular changes. Expert Rev Cardiovasc Ther 2005; 3(5):937-940.
69. Phillips CL, Yee B, Yang Q, et al. Effects of continuous positive airway pressure treatment and withdrawal in patients with obstructive sleep apnea on arterial stiffness and central BP. Chest 2008; 134(1):94-100.
70. Bonsignore MR, Parati G, Insalaco G, et al. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2002; 166(3):279-286.
71. Ito R, Hamada H, Yokoyama A, et al. Successful treatment of obstructive sleep apnea syndrome improves autonomic nervous system dysfunction. Clin Exp Hypertens 2005; 27 (2-3):259-267.
72. Bonsignore MR, Parati G, Insalaco G, et al. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: effects of acute CPAP. Eur Respir J 2006; 27(1):128-135.
73. Noda A, Nakata S, Koike Y, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res 2007; 30(8):669-676.
74. Imadojemu VA, Mawji Z, Kunselman A, et al. Sympathetic chemoreflex responses in obstructive sleep apnea and effects of continuous positive airway pressure therapy. Chest 2007; 131(5):1406-1413.
75. Baruzzi A, Riva R, Cirignotta F, et al. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14(1):83-86.
76. Hedner J, Darpo B, Ejnell H, et al. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8(2):222-229.
77. Sukegawa M, Noda A, Sugiura T, et al. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol 2005; 28(11):519-522.
78. Mills PJ, Kennedy BP, Loredo JS, et al. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006; 100(1):343-348.
79. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96(4):1897-1904.
80. Waradekar NV, Sinoway LI, Zwillich CW, et al. Influence of treatment on muscle sympathetic nerve activity in sleep apnea. Am J Respir Crit Care Med 1996; 153(4 Pt 1):1333-1338.
81. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100 (23):2332-2335.
82. Imadojemu VA, Gleeson K, Quraishi SA, et al. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 2002; 165(7):950-953.
83. Heitmann J, Ehlenz K, Penzel T, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23(2):255-262.
84. Ip MS, Lam B, Chan LY, et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162(6):2166-2171.
85. Schulz R, Schmidt D, Blum A, et al. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55(12):1046-1051.
86. Ohike Y, Kozaki K, Iijima K, et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure-possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005; 69(2):221-226.
87. Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004; 169(3):348-353.
88. Ohga E, Tomita T, Wada H, et al. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 2003; 94(1):179-184.
89. Phillips BG, Narkiewicz K, Pesek CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17(1):61-66.
90. Jordan W, Reinbacher A, Cohrs S, et al. Obstructive sleep apnea: plasma endothelin-1 precursor but not endothelin-1 levels are elevated and decline with nasal continuous positive airway pressure. Peptides 2005; 26(9):1654-1660.
91. Kitahara Y, Hattori N, Yokoyama A, et al. Effect of CPAP on brachial-ankle pulse wave velocity in patients with OSAHS: an open-labelled study. Respir Med 2006; 100(12):2160-2169.
92. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulindependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994; 79(6):1681-1685.
93. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169(2):156-162.
94. Barcelo A, Barbe F, de la Pena M, et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006; 27(4):756-760.
95. Christou K, Kostikas K, Pastaka C, et al. Nasal continuous positive airway pressure treatment reduces systemic oxidative stress in patients with severe obstructive sleep apnea syndrome. Sleep Med 2009; 10(1):87-94.
96. Ehlenz K, Peter JH, Kaffarnik H, et al. Disturbances in volume regulating hormone system-a key to the pathogenesis of hypertension in obstructive sleep apnea syndrome? Pneumologie 1991; 45(suppl 1):239-245.
97. Cahan C, Decker MJ, Arnold JL, et al. Erythropoietin levels with treatment of obstructive sleep apnea. J Appl Physiol 1995; 79(4):1278-1285.
98. Winnicki M, Shamsuzzaman A, Lanfranchi P, et al. Erythropoietin and obstructive sleep apnea. Am J Hypertens 2004; 17(9):783-786.
99. Engleman HM, Gough K, Martin SE, et al. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in "non-dippers". Sleep 1996; 19(5):378-381.
100. Monasterio C, Vidal S, Duran J, et al. Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001; 164(6):939-943.
101. Barnes M, Houston D, Worsnop CJ, et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165(6):773-780.
102. Barnes M, McEvoy RD, Banks S, et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170(6):656-664.
103. Coughlin S, Murgaza J, Mawdsley L, et al. Continuous positive airway pressure treatment reduces the cardiovascular risk factors associated with obstructive sleep apnea [abstract]. In:American Thoracic Society 100th International Conference. Orlando, FL, 2004.
104. Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005; 112(3):375-383.
105. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebocontrolled trial. Chest 2006; 129(6):1459-1467.
106. Usui K, Bradley TD, Spaak J, et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005; 45(12):2008-2011.
107. Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006; 27(9):1106-1113.
108. Saarelainen S, Hasan J, Siitonen S, et al. Effect of nasal CPAP treatment on plasma volume, aldosterone and 24-h blood pressure in obstructive sleep apnoea. J Sleep Res 1996; 5(3):181-185.
109. Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16(4):274-280.